PLAU and ovarian carcinoma: For instance, it was reported that LPA could stimulate production of VEGF [57], interleukine-8 (IL-8) [58] and urokinase plasminogen activator (uPA) [59] in ovarian cancer cells, enhancing hyper-vascularisation processes [3] finally leading to metastases.